Updated Jul 16, 2026
Koppel Adam has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25.00M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | P — Open-market purchase | 1.56M | $16.00 | $25.00M |
| 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | J — Other acquisition / disposition | 4.15M | — | |
| 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | J — Other acquisition / disposition | 16.88M | — |
Koppel Adam is a corporate insider — currently tracked as Insider of Kailera Therapeutics, Inc. (KLRA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($25.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Koppel Adam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.